Bevacizumab modulates epithelial-to-mesenchymal transition in the retinal pigment epithelial cells via connective tissue growth factor up-regulation

Induction of interleukin-8 gene expression and protein secretion by C-reactive protein in ARPE-19 cells

(2010) Yu Wang et al.   EXPERIMENTAL EYE RESEARCH

A review of clinical trials of anti-VEGF agents for diabetic retinopathy

(2010) Benjamin P. Nicholson et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

The Relation Between Bevacizumab Injection and the Formation of Subretinal Fibrosis in Diabetic Patients with Panretinal Photocoagulation

(2010) Cosar Batman et al.   OPHTHALMIC SURGERY LASERS & IMAGING

Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration at Twenty-four Months: The Pan-American Collaborative Retina Study

(2010) J. Fernando Arevalo et al.   OPHTHALMOLOGY

Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: The Second Year of a Prospective Study

(2009) Ziad F. Bashshur et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

Introduction: Understanding the Role of Angiogenesis and Antiangiogenic Agents in Age-Related Macular Degeneration

(2009) Susan B. Bressler   OPHTHALMOLOGY

The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy

(2008) Esther J. Kuiper et al.   PLoS One